Valuation: Sight Sciences, Inc.

Market Cap 589M 535M 494M 446M 842M 55.27B 872M 5.94B 2.35B 29.66B 2.21B 2.16B 93.94B P/E 2026 *
-19.1x
P/E 2027 * -27.2x
Enterprise Value 558M 507M 468M 423M 798M 52.38B 826M 5.63B 2.23B 28.11B 2.09B 2.05B 89.03B EV / Sales 2026 *
6.02x
EV / Sales 2027 * 5.48x
Free-Float
80.37%
Yield 2026 *
-
Yield 2027 * -
1 day-2.22%
1 week+5.06%
Current month+13.63%
1 month+20.34%
3 months+30.10%
6 months+112.65%
Current year+33.54%
1 week 10.5
Extreme 10.505
11.6
1 month 8.09
Extreme 8.09
11.6
Current year 3.38
Extreme 3.378
11.6
1 year 3.38
Extreme 3.378
11.6
3 years 2.03
Extreme 2.03
11.6
5 years 1.04
Extreme 1.04
23.03
10 years 1.04
Extreme 1.04
42.57
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 56 31/12/2009
Chief Executive Officer 51 31/12/2009
Director of Finance/CFO 43 04/11/2025
Director TitleAgeSince
Director/Board Member 51 31/12/2009
Director/Board Member 56 31/12/2009
Chairman 74 31/12/2016
Date Insider Type Main position Quantity % Market Cap. Importance
02/10/26 Sell

Chief Operating Officer

-25,260 0.0459%
02/10/26 Sell

Chief Financial Officer

-7,208 0.0131%
02/10/26 Sell

Executive/Senior Manager

-2,988 0.0054%
Change 5-day change 1-year change 3-year change Capi.($)
-2.22%+5.06%+48.95%+411.59% 602M
-0.99%-2.26%-17.72%+9.64% 188B
+0.02%+1.06%+7.31%+38.99% 126B
+0.35%-4.65%-14.22%+9.55% 118B
+1.18%-4.80%-42.14%+3.55% 92.48B
-0.58%+7.01%-1.38%+84.73% 68.51B
-0.72%+2.17%+12.14%-7.40% 59.39B
-0.51%+3.64%+1.55%+52.13% 55.48B
+0.19%+1.10%-2.01%+43.15% 49.62B
+1.27%+1.37%+0.71%-1.96% 35.17B
Average -0.20%-0.00%-0.68%+64.40% 79B
Weighted average by Cap. -0.11%-0.63%-9.23%+23.65%

Financials

2026 *2027 *
Net sales 92.59M 84.12M 77.72M 70.2M 132M 8.69B 137M 935M 370M 4.67B 347M 340M 14.78B 104M 94.37M 87.19M 78.76M 149M 9.75B 154M 1.05B 415M 5.23B 390M 382M 16.58B
Net income -30.26M -27.49M -25.4M -22.94M -43.29M -2.84B -44.82M -305M -121M -1.52B -114M -111M -4.83B -22.32M -20.28M -18.73M -16.92M -31.93M -2.1B -33.06M -225M -89.27M -1.12B -83.75M -81.98M -3.56B
Net Debt -30.76M -27.94M -25.82M -23.32M -44.01M -2.89B -45.56M -310M -123M -1.55B -115M -113M -4.91B -19.6M -17.81M -16.45M -14.86M -28.05M -1.84B -29.04M -198M -78.41M -988M -73.56M -72M -3.13B
Projected Income Statement - Annual - Sight Sciences, Inc.
Logo Sight Sciences, Inc.
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Employees
186
Date Price Change Volume
16/11/26 US$10.59 -2.22% 189,200
13/11/26 US$10.83 -1.46% 223,730
12/11/26 US$10.99 +0.64% 459,127
11/11/26 US$10.92 +1.58% 249,736
10/11/26 US$10.75 -2.36% 466,953
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Sight Sciences, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
10.59USD
Average target price
12.25USD
Spread / Average Target
+15.68%
  1. Stock Market
  2. Stocks
  3. SGHT Stock